Akèy › Sipwa › Kalifòni › San Diego
Etid klinik pou Sipwa nan San Diego, CA
13 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- Artemis Insitute for Clin Res, San Diego
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- Artemis Institute for Clinical Research, San Diego
- Scripps Whittier Diabetes Institute, La Jolla · 11 mi lwen
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Acclaim Clinical Research, San Diego
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- Artemis Institute for Clinical Research, LLC, San Diego
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Artemis Insitute for Clin Res, San Diego
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, San Diego
- ACCOMPLISH-2 Research Site, La Jolla · 11 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Apex Clinical Research, San Diego
- Artemis Institute for Clinical Research, San Diego
Effects of Watermelon or Low-fat Cookie Consumption on Wellness
Ap rekriteVolontè an sante akeyi
- School of Exercise and Nutritional Sciences, San Diego
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Apex Clinical Research, San Diego
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, San Diego
- ACCOMPLISH-1 Research Site, La Jolla · 11 mi lwen
Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer
Ap rekrite
- University of California San Diego, La Jolla · 11 mi lwen
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
Ap rekrite
- University of California San Diego Altman Clinical and Translational Research Institute, La Jolla · 11 mi lwen
Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
Ap rekriteVolontè an sante akeyi
- San Diego State University, San Diego
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan San Diego
- Kansè Poumon ki pa ti selil48 etid
- Kansè nan tete41 etid
- Kansè (tout kalite)32 etid
- Kansè pwostat31 etid
- Kansè Metastatik30 etid
- Kansè kolorektal25 etid
- Kansè pankreyas24 etid
- Kansè ovè24 etid
- Kansè poumon23 etid
- Ensifizyans kadyak23 etid
- Obèsite23 etid
- Depresyon21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.